Avacta Group任命David Liebowitz博士为首席医疗官,领导癌症治疗的发展。 Avacta Group appoints Dr. David Liebowitz as Chief Medical Officer to lead cancer therapy development.

设在联合王国的生命科学公司Avacta Group已任命David Liebowitz博士为首席医务官,领导其有针对性的癌症治疗临床战略。 Avacta Group, a UK-based life sciences company, has appointed Dr. David Liebowitz as its Chief Medical Officer to lead its clinical strategy for targeted cancer therapies. Liebowitz拥有30多年的经验,在药物开发方面拥有广泛的专门知识。 Liebowitz, with over 30 years of experience, brings extensive expertise in drug development. 此外,该公司增加了Yulii Bogatyrenko作为企业发展顾问,以加强公司增长战略。 Additionally, the company has added Yulii Bogatyrenko as a business development advisor to enhance its corporate growth strategy.